Literature DB >> 21826540

What are risk factors for local recurrence of deep high-grade soft-tissue sarcomas?

Chigusa Sawamura1, Seiichi Matsumoto, Takashi Shimoji, Taisuke Tanizawa, Keisuke Ae.   

Abstract

BACKGROUND: Patients with local recurrence of soft-tissue sarcomas have a poor overall survival. High-grade, soft-tissue sarcomas in deep locations may have a poorer prognosis regarding local recurrence than low-grade sarcomas or those located superficially. Although previous reports evaluated tumors at various depths, it is unclear what factors influence recurrence of deep, high-grade sarcomas. QUESTIONS/PURPOSES: We therefore determined whether possible risk factors (tumor size, location, histologic subtype, unplanned excision, local recurrence at presentation, metastasis at diagnosis, surgical procedure, surgical margin, and adjuvant treatments) influenced local recurrence of deep, high-grade, soft-tissue sarcomas. PATIENTS AND METHODS: We retrospectively reviewed 433 patients with deep, high-grade, soft-tissue sarcomas surgically treated between 1985 and 2005. For each patient, we reviewed tumor size, location, histologic subtype, unplanned excision, local recurrence at presentation, metastasis at diagnosis, surgical procedure, surgical margin, and adjuvant treatments and determined the effect of each prognostic variable on local recurrence. The minimum followup was 1 month (median, 51 months; range, 1-305 months).
RESULTS: Forty-seven patients had local recurrence at a median of 10.7 months. Local recurrence at presentation, metastasis at diagnosis, and positive margins independently predicted local recurrence. No other factors independently predicted local recurrence.
CONCLUSIONS: Unplanned excisions did not increase the rate of local recurrence of deep, high-grade, soft-tissue sarcomas if treated appropriately. Aggressiveness of tumor represented by metastasis or local recurrence at presentation may be a risk for local recurrence. LEVEL OF EVIDENCE: Level II, prognostic study. See Guidelines for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2012        PMID: 21826540      PMCID: PMC3270179          DOI: 10.1007/s11999-011-2017-5

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  16 in total

1.  Influence of local recurrence on the prognosis of soft-tissue sarcomas.

Authors:  T Ueda; H Yoshikawa; S Mori; N Araki; A Myoui; S Kuratsu; A Uchida
Journal:  J Bone Joint Surg Br       Date:  1997-07

2.  Subcutaneous sarcoma. A population-based study of 129 patients.

Authors:  A Rydholm; P Gustafson; B Rööser; H Willén; N O Berg
Journal:  J Bone Joint Surg Br       Date:  1991-07

3.  The impact of previous surgical manipulation of subcutaneous sarcoma on oncologic outcome.

Authors:  Bruce T Rougraff; Kenneth Davis; Terence Cudahy
Journal:  Clin Orthop Relat Res       Date:  2005-09       Impact factor: 4.176

4.  Local recurrence after initial multidisciplinary management of soft tissue sarcoma: is there a way out?

Authors:  Sarantis Abatzoglou; Robert E Turcotte; Abdurahman Adoubali; Marc H Isler; David Roberge
Journal:  Clin Orthop Relat Res       Date:  2010-11       Impact factor: 4.176

5.  Localized extremity soft tissue sarcoma: an analysis of factors affecting survival.

Authors:  C Collin; J Godbold; S Hajdu; M Brennan
Journal:  J Clin Oncol       Date:  1987-04       Impact factor: 44.544

6.  A comparison of the prognoses for deep and subcutaneous sarcomas of the extremities.

Authors:  T D Peabody; D Monson; A Montag; M J Schell; H Finn; M A Simon
Journal:  J Bone Joint Surg Am       Date:  1994-08       Impact factor: 5.284

7.  The surgical margin in soft-tissue sarcoma.

Authors:  R S Bell; B O'Sullivan; F F Liu; J Powell; F Langer; V L Fornasier; B Cummings; P N Miceli; N Hawkins; I Quirt
Journal:  J Bone Joint Surg Am       Date:  1989-03       Impact factor: 5.284

8.  Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma.

Authors:  S Singer; J M Corson; G D Demetri; E A Healey; K Marcus; T J Eberlein
Journal:  Ann Surg       Date:  1995-02       Impact factor: 12.969

9.  High-grade extremity soft tissue sarcomas: factors predictive of local recurrence and its effect on morbidity and mortality.

Authors:  Fritz C Eilber; Gerald Rosen; Scott D Nelson; Michael Selch; Frederick Dorey; Jeffery Eckardt; Frederick R Eilber
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

10.  The effect of an unplanned excision of a soft-tissue sarcoma on prognosis.

Authors:  C R Chandrasekar; H Wafa; R J Grimer; S R Carter; R M Tillman; A Abudu
Journal:  J Bone Joint Surg Br       Date:  2008-02
View more
  8 in total

1.  Does an Algorithmic Approach to Using Brachytherapy and External Beam Radiation Result in Good Function, Local Control Rates, and Low Morbidity in Patients With Extremity Soft Tissue Sarcoma?

Authors:  Jason Klein; Alex Ghasem; Samuel Huntley; Nathan Donaldson; Martin Keisch; Sheila Conway
Journal:  Clin Orthop Relat Res       Date:  2018-03       Impact factor: 4.176

Review 2.  Local recurrence of soft-tissue sarcoma: issues in imaging surveillance strategy.

Authors:  Nisreen S Ezuddin; Juan Pretell-Mazzini; Raphael L Yechieli; Darcy A Kerr; Breelyn A Wilky; Ty K Subhawong
Journal:  Skeletal Radiol       Date:  2018-05-21       Impact factor: 2.199

Review 3.  Management of musculoskeletal tumours of the extremity in low-resource settings.

Authors:  Nicolas de l'Escalopier; Laurent Mathieu; Philippe Anract; David Biau
Journal:  Int Orthop       Date:  2021-09-07       Impact factor: 3.075

4.  How long should we follow patients with soft tissue sarcomas?

Authors:  Chigusa Sawamura; Seiichi Matsumoto; Takashi Shimoji; Atsushi Okawa; Keisuke Ae
Journal:  Clin Orthop Relat Res       Date:  2014-03       Impact factor: 4.176

5.  Designing a Rational Follow-Up Schedule for Patients with Extremity Soft Tissue Sarcoma.

Authors:  David A J Wilson; Aaron Gazendam; Julia Visgauss; David Perrin; Anthony M Griffin; Peter W Chung; Charles N Catton; David Shultz; Peter C Ferguson; Jay S Wunder
Journal:  Ann Surg Oncol       Date:  2020-03-09       Impact factor: 5.344

6.  Use of liquid biopsies to monitor disease progression in a sarcoma patient: a case report.

Authors:  Heidi M Namløs; Olga Zaikova; Bodil Bjerkehagen; Daniel Vodák; Eivind Hovig; Ola Myklebost; Kjetil Boye; Leonardo A Meza-Zepeda
Journal:  BMC Cancer       Date:  2017-01-06       Impact factor: 4.430

7.  Preoperative Ultrasonographic Evaluation for Malignancy of Soft-Tissue Sarcoma: A Retrospective Study.

Authors:  Takeshi Morii; Tomonori Kishino; Naoko Shimamori; Mitsue Motohashi; Hiroaki Ohnishi; Keita Honya; Takayuki Aoyagi; Takashi Tajima; Shoichi Ichimura
Journal:  Open Orthop J       Date:  2018-03-16

8.  Prediction of Soft Tissue Sarcoma from Clinical Characteristics and Laboratory Data.

Authors:  Taketsugu Fujibuchi; Joji Miyawaki; Teruki Kidani; Hiroshi Imai; Hiromasa Miura
Journal:  Cancers (Basel)       Date:  2020-03-13       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.